Cargando…
Intra-arterial hepatic beads loaded with irinotecan (DEBIRI) with mFOLFOX6 in unresectable liver metastases from colorectal cancer: a Phase 2 study
BACKGROUND: Chemo-embolisation with drug-eluting beads loaded with irinotecan (DEBIRI) increased survival as compared with intravenous irinotecan in chemorefractory patients with liver-dominant metastases from colorectal cancer (LMCRC). First-line DEBIRI with systemic chemotherapy may increase survi...
Autores principales: | Pernot, Simon, Pellerin, Olivier, Artru, Pascal, Montérymard, Carole, Smith, Denis, Raoul, Jean-Luc, De La Fouchardière, Christelle, Dahan, Laetitia, Guimbaud, Rosine, Sefrioui, David, Jouve, Jean-Louis, Lepage, Côme, Tougeron, David, Taieb, Julien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7435188/ https://www.ncbi.nlm.nih.gov/pubmed/32507854 http://dx.doi.org/10.1038/s41416-020-0917-4 |
Ejemplares similares
-
Transarterial Chemoembolization of Metastatic Colorectal Carcinoma with Drug-Eluting Beads, Irinotecan (DEBIRI): Multi-Institutional Registry
por: Martin, Robert C. G., et al.
Publicado: (2009) -
Cediranib with mFOLFOX6 vs bevacizumab with mFOLFOX6 in previously treated metastatic colorectal cancer
por: Cunningham, D, et al.
Publicado: (2013) -
First human study in treatment of unresectable liver metastases from colorectal cancer with irinotecan-loaded beads (DEBIRI)
por: EICHLER, K., et al.
Publicado: (2012) -
Feasibility, safety and pharmacokinetic study of hepatic administration of drug-eluting beads loaded with irinotecan (DEBIRI) followed by intravenous administration of irinotecan in a porcine model
por: Lewis, Andrew L., et al.
Publicado: (2012) -
Pathological Evaluation of Resected Colorectal Liver Metastases: mFOLFOX6 Plus Bevacizumab versus mFOLFOX6 Plus Cetuximab in the Phase II ATOM Trial
por: Takahashi, Takao, et al.
Publicado: (2022)